Rising costs are not yet a problem for equities

In this AFR article, Jun Bei Liu explains how large fiscal and monetary stimulus measures have contributed to surges in commodity prices and increased input price measures. She discusses the factor at play, and what this means for equity markets.

Jun Bei Liu

Rising costs are not yet a problem for equities

May 17, 2021
In this AFR article, Jun Bei Liu explains how large fiscal and monetary stimulus measures have contributed to surges in commodity prices and increased input price measures. She discusses the factor at play, and what this means for equity markets.
Read Transcript

Surging commodity prices, supply component disruptions and faster than expected tightening in labour market conditions across many economies, including Australia, are now causing investor concerns around rising input cost pressures and the likely negative impact this might have on corporate profit margins, earnings and ultimately the ability of the equity market to move higher.

The potential for higher inflation to begin seeping into the corporate cost base should come as no surprise to anyone who has been watching the narrative around broader inflationary pressures.

Extraordinary fiscal and monetary policy settings around the world, on top of a faster than expected demand and activity rebound has seen sharp increases in commodity prices, rising borrowing costs and labour tightness as a result of border controls.

One quarter of the companies presenting at the recent Macquarie conference highlighted the impact of input cost pressures and how it is taking some gloss off the strong economic and earnings rebound expected for the next 12 months.

Traditionally rising input costs can be problematic for margins and corporate profitability, but at this stage we see it as something which is transitory and stock and sector specific, rather than something which will prompt a broad based sell off across the Australian equity market (as some have predicted).

 

The factors at play

To explore this further, a number of factors should be considered.

Large stimulus packages designed to offset the pandemic have been the key contributing factor to input price pressures, particularly within the commodity space. This means that the supply side response and a tapering of demand could see much of the price increases to be transitory rather than permanent.

Rising input costs – predominantly raw materials and labour – are not going to have a uniform impact on all businesses and its ultimate impact will depend on the unique circumstances of each company.

 

“Stay invested and stay active.”

Corporates in Australia have been running quite lean on the cost side, courtesy of a decade of cost cutting due to weak demand and lack of investment. We think there is some capacity to absorb minor and transitory cost increases without a major impact on earnings outlook.

Much of the cost increases that corporates face today are cyclical and are the result of an improving economic backdrop. Historical evidence suggests that rising input costs are closely correlated with improving margins (rather than declining margins) because of companies’ ability to pass on costs increases to the final consumer in a strong demand environment.

Australian corporates are underleveraged and while rising borrowing costs may impact earnings, debt burdens remain low, especially in comparison to the US where low borrowing rates have driven a raft of debt financed stock buybacks.

A large part of the Australian equity market is a positive beneficiary of rising commodity prices. The resources sector comprises nearly one-quarter of the Australian market capitalisation. A bull market in commodity prices has the potential to create a significant boost to overall earnings as well as provide strong sector leadership for the equity market even if it is having the opposite effect on some stocks and sectors.

It would be unusual for cost pressure to dominate broader earnings tailwinds at this stage of the economic recovery and it may simply be a case where corporates choose to absorb cost increases in an effort to gain market share.

 

Bull market intact

While we remain vigilant for further cost pressures as well as signs that these might be broadening out, we don’t see this as something which undermines the equity bull market.

Australia is currently in the midst of the strongest earnings upgrade cycle in two decades as analysts chase an economic recovery which has surprised substantially and consistently on the upside. Leading activity indicators signal that this trend is likely to continue well into the second half of the year.

In addition, the recent 2021/22 Federal Budget was pro-growth and highly expansionary. Combined with the RBA’s commitment to lower interest rates, this should prove to be a strong tailwind for the equity market irrespective of rising cost pressures (though it may act as a headwind for some areas of the market).

This is further reason to favour active investors for their ability to cherry pick the best companies to thrive in the current environment.

Stay invested and stay active.

 

This article was originally posted on The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

 

Surging commodity prices, supply component disruptions and faster than expected tightening in labour market conditions across many economies, including Australia, are now causing investor concerns around rising input cost pressures and the likely negative impact this might have on corporate profit margins, earnings and ultimately the ability of the equity market to move higher.

The potential for higher inflation to begin seeping into the corporate cost base should come as no surprise to anyone who has been watching the narrative around broader inflationary pressures.

Extraordinary fiscal and monetary policy settings around the world, on top of a faster than expected demand and activity rebound has seen sharp increases in commodity prices, rising borrowing costs and labour tightness as a result of border controls.

One quarter of the companies presenting at the recent Macquarie conference highlighted the impact of input cost pressures and how it is taking some gloss off the strong economic and earnings rebound expected for the next 12 months.

Traditionally rising input costs can be problematic for margins and corporate profitability, but at this stage we see it as something which is transitory and stock and sector specific, rather than something which will prompt a broad based sell off across the Australian equity market (as some have predicted).

 

The factors at play

To explore this further, a number of factors should be considered.

Large stimulus packages designed to offset the pandemic have been the key contributing factor to input price pressures, particularly within the commodity space. This means that the supply side response and a tapering of demand could see much of the price increases to be transitory rather than permanent.

Rising input costs – predominantly raw materials and labour – are not going to have a uniform impact on all businesses and its ultimate impact will depend on the unique circumstances of each company.

 

“Stay invested and stay active.”

Corporates in Australia have been running quite lean on the cost side, courtesy of a decade of cost cutting due to weak demand and lack of investment. We think there is some capacity to absorb minor and transitory cost increases without a major impact on earnings outlook.

Much of the cost increases that corporates face today are cyclical and are the result of an improving economic backdrop. Historical evidence suggests that rising input costs are closely correlated with improving margins (rather than declining margins) because of companies’ ability to pass on costs increases to the final consumer in a strong demand environment.

Australian corporates are underleveraged and while rising borrowing costs may impact earnings, debt burdens remain low, especially in comparison to the US where low borrowing rates have driven a raft of debt financed stock buybacks.

A large part of the Australian equity market is a positive beneficiary of rising commodity prices. The resources sector comprises nearly one-quarter of the Australian market capitalisation. A bull market in commodity prices has the potential to create a significant boost to overall earnings as well as provide strong sector leadership for the equity market even if it is having the opposite effect on some stocks and sectors.

It would be unusual for cost pressure to dominate broader earnings tailwinds at this stage of the economic recovery and it may simply be a case where corporates choose to absorb cost increases in an effort to gain market share.

 

Bull market intact

While we remain vigilant for further cost pressures as well as signs that these might be broadening out, we don’t see this as something which undermines the equity bull market.

Australia is currently in the midst of the strongest earnings upgrade cycle in two decades as analysts chase an economic recovery which has surprised substantially and consistently on the upside. Leading activity indicators signal that this trend is likely to continue well into the second half of the year.

In addition, the recent 2021/22 Federal Budget was pro-growth and highly expansionary. Combined with the RBA’s commitment to lower interest rates, this should prove to be a strong tailwind for the equity market irrespective of rising cost pressures (though it may act as a headwind for some areas of the market).

This is further reason to favour active investors for their ability to cherry pick the best companies to thrive in the current environment.

Stay invested and stay active.

 

This article was originally posted on The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

 

Disclaimer: This material has been prepared by Australian Financial Review, published on May 17, 2021. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.